Hello NASPAG Members, Friends, and Colleagues!  We are excited to invite you to the fourth installment of our new NASPAG monthly webinar series “Current Management of Central Precocious Puberty”, on Wednesday, January 15th at 7:30 pm CT (8:30 pm ET). This webinar is sponsored by Tolmar.   Current Management of Central Precocious Puberty This webinar will review clinical management updates and issues in Central Precocious Puberty (CPP).  It will also discuss the efficacy, safety and unique product features of FENSOLVI® (leuprolide acetate) for injectable suspension, indicated for the treatment of CPP. Free to register for all NASPAG members! $10 for non-members. Wednesday, January 15, 2025 7:30-8:30 p.m. CT (8:30-9:30 p.m. ET; 6:30-7:30 p.m. PT) Session Objectives:  Define Central Precocious Puberty (CPP) Review diagnostic criteria and define treatment goals Review currently available treatment options and define treatment success Discuss when GnRHa treatment should start or end Review the clinical data and product features of Fensolvi Speaker: Dr. Karen Klein, Interim Chief of the Endocrinology/Diabetes Division & Clinical Professor of Pediatrics at Rady Children’s Hospital, University of California San Diego   Moderator:  Dr Lauren Kanner, Clinical Associate Professor of Pediatrics-Endocrinology and Diabetes, Carver College of Medicine- University of Iowa and NASPAG Member   Please use the link below to register and note if you are a non-NASPAG member you will be asked to create a NASPAG account (at no cost to you) in order to register for the event. https://naspag.memberclicks.net/jan_25_webinar We hope you can join us on January 15th at 8:30 pm ET! Kate McCracken MD and Megan Harrison MD, NASPAG Board of Directors, Webinar Co-Leads   Please see Full Prescribing Information for additional important safety information.